Elekta
Elekta develops precision radiation medicine used to treat a range of cancers, including brain tumours, breast cancer, kidney cancer, lung cancer, pancreatic cancer and prostate cancer, as well as certain neurological disorders.
Elekta has raised €100M across 1 funding round from 1 investor, most recently a Debt round in Aug 2026. Based in Stockholm, Sweden; active in Healthtech. Data as of 28 Oct 2026.
Stockholm, Swedenwww.elekta.com ↗
Total raised
€100M
€100,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2026-08
latest 2026-08
Funding by year
EUR raised per year · 2026 YTDElekta — funding by year — interactive chart.
Data table
| Elekta — funding by year | |
|---|---|
| 2026 | €100M |
Signals
High confidenceRaise-next likelihood28
base rate 45% for Debt
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-08-31 | Debt | €100M | European Investment Bank (EIB) | View deal → |